Paclitaxel, UFT, and calcium folinate in metastatic breast cancer

ONCOLOGY

Volumn 13, Issue 7 SUPPL., 1999, Pages 69-70

  Dickson, Natalie R ^a   Nicholson, Brenda P ^b   Hande, Kenneth ^b   Blanke, Charles ^b   Johnson, David ^b   Cohen, Alan ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SAINT THOMAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINATE CALCIUM; PACLITAXEL; TEGAFUR; URACIL;

ADULT; AGED; BREAST CANCER; CANCER GRADING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG TOLERANCE; FEMALE; HUMAN; HYPOTENSION; METASTASIS; PALLIATIVE THERAPY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0032775864     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Nicholson B, Paul D, Hande KR, et al: A phase II trial of paclitaxel (T), 5-fIuorouracil (5- FU), and leucovorin (L) in metastatic breast cancer (MBC) (abstract 72). Proc Am Soc Clin Oncol 15:102, 1996.